Suppr超能文献

慢性阻塞性肺疾病患者侵袭性肺曲霉病的改良诊断标志物。

Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients.

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, Guangzhou, China.

出版信息

Front Cell Infect Microbiol. 2024 Apr 3;14:1294971. doi: 10.3389/fcimb.2024.1294971. eCollection 2024.

Abstract

BACKGROUND

The prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the efficacy of current diagnostic methods is limited. Consequently, there is a need for novel approaches for early IPA detection.

METHODS

This retrospective study involved 383 hospitalized COPD patients with GOLD stages III and IV. The IPA group (67 patients) and non-IPA group (316 patients) were identified at the First Affiliated Hospital of Guangzhou Medical University between January 2016 and February 2022. We analyzed common serological indicators in our hospital to identify predictive indicators for the early diagnosis of IPA in COPD patients.

RESULTS

The sensitivity and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), lactate dehydrogenase (LDH), and ceruloplasmin (CER) for diagnosing IPA in COPD patients were as follows: CRP (91.2%, 57.7%), ESR (77.5%, 73.0%), PCT (60.5%, 71.4%), LDH (50.0%, 88.8%), and CER (60.7%, 74.3%). Combinations of biomarkers, such as CRP-ESR, CRP-LDH, ESR-LDH, ESR-CER, and LDH-CER, showed promising diagnostic potential, with larger area under the curve (AUC) values for IPA diagnosis in COPD patients. However, no statistically significant difference was observed between the diagnostic efficacy of single biomarkers and combined biomarkers. Notably, compared to those in the unassisted ventilation group, the patients in the assisted ventilation group (including noninvasive ventilation and tracheal intubation/incision-assisted ventilation group) exhibited significantly greater PCT and LDH levels, while the CER significantly decreased (p=0.021). There were no significant differences in biomarker levels between the ICU group and the non-ICU group. CRP (p<0.01), ESR (p=0.028), PCT (p<0.01), and CER (p<0.01) were positively correlated with hospitalization duration, whereas LDH was not correlated with hospitalization duration.

CONCLUSION

Our study highlights the diagnostic potential of CRP, ESR, PCT, LDH, and CER for IPA in COPD patients. CRP and LDH can also initially predict the need for assisted ventilation, while CRP can initially estimate the length of hospitalization. This study represents the first report of the potential of CER for diagnosing IPA, suggesting its significance for further research.

摘要

背景

慢性阻塞性肺疾病(COPD)患者侵袭性肺曲霉病(IPA)的患病率稳步上升,导致死亡率居高不下。尽管早期诊断可以显著降低死亡率,但目前诊断方法的疗效有限。因此,需要新的方法来早期检测 IPA。

方法

这是一项回顾性研究,涉及广州医科大学第一附属医院 2016 年 1 月至 2022 年 2 月收治的 383 例 GOLD 分期为 III 和 IV 期的 COPD 住院患者。IPA 组(67 例)和非 IPA 组(316 例)。我们分析了我院常见的血清学指标,以确定预测 COPD 患者 IPA 早期诊断的指标。

结果

C 反应蛋白(CRP)、红细胞沉降率(ESR)、降钙素原(PCT)、乳酸脱氢酶(LDH)和铜蓝蛋白(CER)对 COPD 患者 IPA 诊断的灵敏度和特异性分别为:CRP(91.2%,57.7%)、ESR(77.5%,73.0%)、PCT(60.5%,71.4%)、LDH(50.0%,88.8%)和 CER(60.7%,74.3%)。CRP-ESR、CRP-LDH、ESR-LDH、ESR-CER 和 LDH-CER 等生物标志物组合具有较好的诊断潜力,对 COPD 患者 IPA 的诊断具有较大的曲线下面积(AUC)值。然而,单标志物和组合标志物的诊断效果之间没有统计学上的显著差异。值得注意的是,与未接受辅助通气的患者相比,接受辅助通气(包括无创通气和气管插管/切开辅助通气)的患者 PCT 和 LDH 水平显著升高,而 CER 显著降低(p=0.021)。生物标志物水平在 ICU 组和非 ICU 组之间没有差异。CRP(p<0.01)、ESR(p=0.028)、PCT(p<0.01)和 CER(p<0.01)与住院时间呈正相关,而 LDH 与住院时间无相关性。

结论

本研究强调了 CRP、ESR、PCT、LDH 和 CER 对 COPD 患者 IPA 的诊断潜力。CRP 和 LDH 还可以初步预测是否需要辅助通气,而 CRP 可以初步估计住院时间。本研究首次报道了 CER 诊断 IPA 的潜力,提示其对进一步研究的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b5/11021593/3f4b5dc6b146/fcimb-14-1294971-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验